128 related articles for article (PubMed ID: 36841969)
21. Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies.
Ferreira WA; Chweih H; Lanaro C; Almeida CB; Brito PL; Gotardo EMF; Torres L; Miguel LI; Franco-Penteado CF; Leonardo FC; Garcia F; Saad STO; Frenette PS; Brockschnieder D; Costa FF; Stasch JP; Sandner P; Conran N
J Pharmacol Exp Ther; 2020 Sep; 374(3):469-478. PubMed ID: 32631869
[TBL] [Abstract][Full Text] [Related]
22. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
Luchtman-Jones L; Pressel S; Hilliard L; Brown RC; Smith MG; Thompson AA; Lee MT; Rothman J; Rogers ZR; Owen W; Imran H; Thornburg C; Kwiatkowski JL; Aygun B; Nelson S; Roberts C; Gauger C; Piccone C; Kalfa T; Alvarez O; Hassell K; Davis BR; Ware RE
Am J Hematol; 2016 Feb; 91(2):238-42. PubMed ID: 26615793
[TBL] [Abstract][Full Text] [Related]
23. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.
Opoka RO; Ndugwa CM; Latham TS; Lane A; Hume HA; Kasirye P; Hodges JS; Ware RE; John CC
Blood; 2017 Dec; 130(24):2585-2593. PubMed ID: 29051184
[TBL] [Abstract][Full Text] [Related]
24. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.
Estepp JH; Winter B; Johnson M; Smeltzer MP; Howard SC; Hankins JS
Pediatr Blood Cancer; 2014 Nov; 61(11):2031-6. PubMed ID: 25132074
[TBL] [Abstract][Full Text] [Related]
25. Hydroxycarbamide: clinical aspects.
Ware RE
C R Biol; 2013 Mar; 336(3):177-82. PubMed ID: 23643402
[TBL] [Abstract][Full Text] [Related]
26. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
Aygun B; Mortier NA; Smeltzer MP; Shulkin BL; Hankins JS; Ware RE
Am J Hematol; 2013 Feb; 88(2):116-9. PubMed ID: 23255310
[TBL] [Abstract][Full Text] [Related]
27. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
Steinberg MH; Barton F; Castro O; Pegelow CH; Ballas SK; Kutlar A; Orringer E; Bellevue R; Olivieri N; Eckman J; Varma M; Ramirez G; Adler B; Smith W; Carlos T; Ataga K; DeCastro L; Bigelow C; Saunthararajah Y; Telfer M; Vichinsky E; Claster S; Shurin S; Bridges K; Waclawiw M; Bonds D; Terrin M
JAMA; 2003 Apr; 289(13):1645-51. PubMed ID: 12672732
[TBL] [Abstract][Full Text] [Related]
28. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE;
Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
[TBL] [Abstract][Full Text] [Related]
29. Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004-2019.
Tang AY; Zhou M; Maillis AN; Lai KW; Lane PA; Snyder AB
Pediatr Blood Cancer; 2023 Mar; 70(3):e30152. PubMed ID: 36579749
[TBL] [Abstract][Full Text] [Related]
30. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
Kinney TR; Helms RW; O'Branski EE; Ohene-Frempong K; Wang W; Daeschner C; Vichinsky E; Redding-Lallinger R; Gee B; Platt OS; Ware RE
Blood; 1999 Sep; 94(5):1550-4. PubMed ID: 10477679
[TBL] [Abstract][Full Text] [Related]
31. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
[TBL] [Abstract][Full Text] [Related]
32. Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines.
Reeves SL; Peng HK; Wing JJ; Cogan LW; Goel A; Anders D; Green NS; Lisabeth LD; Dombkowski KJ
JAMA Netw Open; 2023 Mar; 6(3):e234584. PubMed ID: 36961463
[TBL] [Abstract][Full Text] [Related]
33. Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia.
Crosby LE; Shook LM; Ware RE; Brinkman WB
Pediatr Blood Cancer; 2015 Feb; 62(2):184-185. PubMed ID: 25308571
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.
Ofakunrin AOD; Oguche S; Adekola K; Okpe ES; Afolaranmi TO; Diaku-Akinwumi IN; Zoakah AI; Sagay AS
J Trop Pediatr; 2020 Jun; 66(3):290-298. PubMed ID: 31608959
[TBL] [Abstract][Full Text] [Related]
35. Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea.
Singh SA; Koumbourlis AC; Aygun B
Pediatr Blood Cancer; 2008 Jun; 50(6):1258-60. PubMed ID: 18293380
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.
Altura RA; Wang WC; Wynn L; Altura BM; Altura BT
J Pediatr; 2002 May; 140(5):565-9. PubMed ID: 12032523
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease.
Oliveira EAM; Boy KA; Santos APP; Machado CDS; Velloso-Rodrigues C; Gerheim PSAS; Mendonça LM
Einstein (Sao Paulo); 2019 Sep; 17(4):eAO4742. PubMed ID: 31508660
[TBL] [Abstract][Full Text] [Related]
38. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.
Zimmerman SA; Schultz WH; Davis JS; Pickens CV; Mortier NA; Howard TA; Ware RE
Blood; 2004 Mar; 103(6):2039-45. PubMed ID: 14630791
[TBL] [Abstract][Full Text] [Related]
39. Study of Seminal Fluid Parameters and Fertility of Male Sickle Cell Disease Patients and Potential Impact of Hydroxyurea Treatment.
Sahoo LK; Kullu BK; Patel S; Patel NK; Rout P; Purohit P; Meher S
J Assoc Physicians India; 2017 Jun; 65(6):22-25. PubMed ID: 28782309
[TBL] [Abstract][Full Text] [Related]
40. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
